Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
Quick Stats
Feb 02, 202646.5
AI Score
HOLD0.23
Volume Ratio
Mar 26, 2026
Next Earnings
14
+ve Days (30d)
16
-ve Days (30d)
ACRV Stock Summary
Last updated Feb 02, 2026
ACRV is currently trading at $1.83, positioned above its 200-day moving average of $1.7, indicating a long-term uptrend. The stock has a 52-week range of $1.05 to $8.
Technical Analysis: The 50-day moving average stands at $2.24, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 41.601, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.641, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates ACRV at 46.5/100 with a HOLD recommendation.
ACRV (Acrivon Therapeutics, Inc. Common Stock) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 41.601 |
| CMF (20) | -0.641 |
| ROC (10) | -8.051 |
| ADX (14) | 9.938 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.112 |
| AROONOSC (14) | 42.857 |
| WILLAMS %R (14) | -59.59 |
| MFI (14) | 66.551 |
ACRV Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
ACRV Price vs Max Options Open Interest
ACRV Max Change In Options Open Interest
ACRV Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRV Daily Out of Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRV Daily In the Money Options - Sort by Max open Interest (near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
ACRV Most Active Options by Volume(near term)
2nd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Acrivon Therapeutics, Inc. Common Stock is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
ACRV Moving Averages Analysis
Acrivon Therapeutics, Inc. Common Stock has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Feb 02, 2026
ACRV (Acrivon Therapeutics, Inc. Common Stock) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 1.94 |
| 20 | 2.02 |
| 30 | 2.13 |
| 50 | 2.24 |
| 100 | 2.06 |
| 200 | 1.7 |
ACRV Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 56.5 million |
| Earnings/Share ($) | -2.01 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -1.9638 |
| EPS Estimate Next Year ($) | -1.8625 |
| WallStreet Target Price ($) | 11.5 |
| Most Recent Quarter |
Stock $ACRV is currently trading at $1.65 with huge cash reserves of $134M and big assets worth $200M. There is speculation of a potential short squeeze starting and FDA news coming soon. Investors are optimistic about a $10 price target. The stock has seen a double bottom under $1.40 and is up around 10% so far. Other stocks like $OCTO and $BMNR are being compared to the potential boom of $ACRV.
Updated 2025-09-08 10:00:02